FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213293020> ?p ?o ?g. }

• W3213293020 endingPage "1675" @default.
• W3213293020 startingPage "1665" @default.
• W3213293020 abstract "Kidney impairment of ANCA-associated vasculitides can lead to kidney failure. Patients with kidney failure may suffer from vasculitis relapses but are also at high risk of infections and cardiovascular events, which questions the maintenance of immunosuppressive therapy.Patients with ANCA-associated vasculitides initiating long-term dialysis between 2008 and 2012 in France registered in the national Renal Epidemiology and Information Network registry and paired with the National Health System database were included. We analyzed the proportion of patients in remission off immunosuppression over time and overall and event-free survival on dialysis (considering transplantation as a competing risk). We compared the incidence of vasculitis relapses, serious infections, cardiovascular events, and cancers before and after dialysis initiation.In total, 229 patients were included: 142 with granulomatous polyangiitis and 87 with microscopic polyangiitis. Mean follow-up after dialysis initiation was 4.6±2.7 years; 82 patients received a kidney transplant. The proportion of patients in remission off immunosuppression increased from 23% at dialysis initiation to 62% after 5 years. Overall survival rates on dialysis were 86%, 69%, and 62% at 1, 3, and 5 years, respectively. Main causes of death were infections (35%) and cardiovascular events (26%) but not vasculitis flares (6%). The incidence of vasculitis relapses decreased from 57 to seven episodes per 100 person-years before and after dialysis initiation (P=0.05). Overall, during follow-up, 45% of patients experienced a serious infection and 45% had a cardiovascular event, whereas 13% experienced a vasculitis relapse.The proportion of patients with ANCA-associated vasculitis in remission off immunosuppression increases with time spent on dialysis. In this cohort, patients were far less likely to relapse from their vasculitis than to display serious infectious or cardiovascular events.This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2021_11_08_CJN03190321.mp3." @default.
• W3213293020 created "2021-11-22" @default.
• W3213293020 creator A5005411468 @default.
• W3213293020 creator A5018471206 @default.
• W3213293020 creator A5025424518 @default.
• W3213293020 creator A5040540371 @default.
• W3213293020 creator A5048525538 @default.
• W3213293020 creator A5060793051 @default.
• W3213293020 creator A5067891056 @default.
• W3213293020 creator A5073552416 @default.
• W3213293020 creator A5074097531 @default.
• W3213293020 creator A5074375778 @default.
• W3213293020 creator A5074719517 @default.
• W3213293020 creator A5085831233 @default.
• W3213293020 creator A5087737302 @default.
• W3213293020 creator A5091607425 @default.
• W3213293020 date "2021-11-01" @default.
• W3213293020 modified "2023-10-18" @default.
• W3213293020 title "Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis" @default.
• W3213293020 cites W1128050538 @default.
• W3213293020 cites W1556885643 @default.
• W3213293020 cites W1822283139 @default.
• W3213293020 cites W1890288585 @default.
• W3213293020 cites W1966376339 @default.
• W3213293020 cites W1981923583 @default.
• W3213293020 cites W2006391960 @default.
• W3213293020 cites W2018466091 @default.
• W3213293020 cites W2019184462 @default.
• W3213293020 cites W2020345548 @default.
• W3213293020 cites W2025060860 @default.
• W3213293020 cites W2039920614 @default.
• W3213293020 cites W2052226040 @default.
• W3213293020 cites W2054596819 @default.
• W3213293020 cites W2063332867 @default.
• W3213293020 cites W2078187985 @default.
• W3213293020 cites W2080567030 @default.
• W3213293020 cites W2101711164 @default.
• W3213293020 cites W2113281485 @default.
• W3213293020 cites W2121473391 @default.
• W3213293020 cites W2132820210 @default.
• W3213293020 cites W2133783153 @default.
• W3213293020 cites W2136885213 @default.
• W3213293020 cites W2138139566 @default.
• W3213293020 cites W2145169863 @default.
• W3213293020 cites W2163019124 @default.
• W3213293020 cites W2163274590 @default.
• W3213293020 cites W2171328348 @default.
• W3213293020 cites W28968548 @default.
• W3213293020 cites W2899055848 @default.
• W3213293020 cites W2907412628 @default.
• W3213293020 cites W3005489173 @default.
• W3213293020 cites W3006519940 @default.
• W3213293020 cites W3017992625 @default.
• W3213293020 cites W3031234495 @default.
• W3213293020 doi "https://doi.org/10.2215/cjn.03190321" @default.
• W3213293020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34750159" @default.
• W3213293020 hasPublicationYear "2021" @default.
• W3213293020 type Work @default.
• W3213293020 sameAs 3213293020 @default.
• W3213293020 citedByCount "6" @default.
• W3213293020 countsByYear W32132930202021 @default.
• W3213293020 countsByYear W32132930202022 @default.
• W3213293020 countsByYear W32132930202023 @default.
• W3213293020 crossrefType "journal-article" @default.
• W3213293020 hasAuthorship W3213293020A5005411468 @default.
• W3213293020 hasAuthorship W3213293020A5018471206 @default.
• W3213293020 hasAuthorship W3213293020A5025424518 @default.
• W3213293020 hasAuthorship W3213293020A5040540371 @default.
• W3213293020 hasAuthorship W3213293020A5048525538 @default.
• W3213293020 hasAuthorship W3213293020A5060793051 @default.
• W3213293020 hasAuthorship W3213293020A5067891056 @default.
• W3213293020 hasAuthorship W3213293020A5073552416 @default.
• W3213293020 hasAuthorship W3213293020A5074097531 @default.
• W3213293020 hasAuthorship W3213293020A5074375778 @default.
• W3213293020 hasAuthorship W3213293020A5074719517 @default.
• W3213293020 hasAuthorship W3213293020A5085831233 @default.
• W3213293020 hasAuthorship W3213293020A5087737302 @default.
• W3213293020 hasAuthorship W3213293020A5091607425 @default.
• W3213293020 hasBestOaLocation W32132930201 @default.
• W3213293020 hasConcept C120665830 @default.
• W3213293020 hasConcept C121332964 @default.
• W3213293020 hasConcept C126322002 @default.
• W3213293020 hasConcept C2776015282 @default.
• W3213293020 hasConcept C2778653478 @default.
• W3213293020 hasConcept C2778910314 @default.
• W3213293020 hasConcept C2779134260 @default.
• W3213293020 hasConcept C2779978075 @default.
• W3213293020 hasConcept C2780252810 @default.
• W3213293020 hasConcept C2780303639 @default.
• W3213293020 hasConcept C2781229154 @default.
• W3213293020 hasConcept C2911091166 @default.
• W3213293020 hasConcept C54847362 @default.
• W3213293020 hasConcept C61511704 @default.
• W3213293020 hasConcept C71924100 @default.
• W3213293020 hasConceptScore W3213293020C120665830 @default.
• W3213293020 hasConceptScore W3213293020C121332964 @default.
• W3213293020 hasConceptScore W3213293020C126322002 @default.
• W3213293020 hasConceptScore W3213293020C2776015282 @default.

• next